Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity

Alessandro Sette, John Sidney, Huynh Hoa Bui, Marie France Del Guercio, Jeff Alexander, John Loffredo, David Watkins, Bianca R. Mothé

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The SIV-infected Indian rhesus macaque is the most established model of HIV infection, providing insight into pathogenesis and a system for testing novel vaccines. However, only a limited amount of information is available regarding the peptide-binding motifs and epitopes bound by their class I and class II MHC molecules. In this study, we utilized a library of over 1,000 different peptides and a high throughput MHC-peptide binding assay to detail the binding specificity of the rhesus macaque class I molecule Mamu-A*11. These studies defined the fine specificity of primary anchor positions, and dissected the role of secondary anchors, for peptides of 8-11 residues in length. This detailed information was utilized to develop size-specific polynomial algorithms to predict Mamu-A*11 binding capacity. Testing SIVmac239-derived Mamu-A* 11 binding peptides for recognition by peripheral blood mononuclear cells (PBMC) from Mamu-A*11-positive, SIV-infected macaques, identified five novel SIV-derived Mamu-A*11 epitopes. Finally, we detected extensive cross-reactivity at the binding level between Mamu-A*11 and the mouse H-2 class I molecule K k. Further experiments revealed that three out of four Mamu-A *11 binding peptides which bound Kk and were immunogenic in Kk mice were also recognized in Mamu-A*11-infected macaques. This is the first detailed description of mouse-macaque interspecies cross-reactivity, potentially useful in testing novel vaccines in mice and macaques.

Original languageEnglish
Pages (from-to)53-68
Number of pages16
JournalImmunogenetics
Volume57
Issue number1-2
DOIs
StatePublished - Apr 1 2005
Externally publishedYes

Fingerprint

Macaca
Epitopes
Peptides
Macaca mulatta
Vaccines
Libraries
HIV Infections
Blood Cells

Keywords

  • AIDS
  • Epitope
  • Macaque
  • MHC
  • SIV

ASJC Scopus subject areas

  • Immunology
  • Genetics

Cite this

Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity. / Sette, Alessandro; Sidney, John; Bui, Huynh Hoa; Del Guercio, Marie France; Alexander, Jeff; Loffredo, John; Watkins, David; Mothé, Bianca R.

In: Immunogenetics, Vol. 57, No. 1-2, 01.04.2005, p. 53-68.

Research output: Contribution to journalArticle

Sette, Alessandro ; Sidney, John ; Bui, Huynh Hoa ; Del Guercio, Marie France ; Alexander, Jeff ; Loffredo, John ; Watkins, David ; Mothé, Bianca R. / Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity. In: Immunogenetics. 2005 ; Vol. 57, No. 1-2. pp. 53-68.
@article{554b725b65694145bbf5641fdc9514ce,
title = "Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity",
abstract = "The SIV-infected Indian rhesus macaque is the most established model of HIV infection, providing insight into pathogenesis and a system for testing novel vaccines. However, only a limited amount of information is available regarding the peptide-binding motifs and epitopes bound by their class I and class II MHC molecules. In this study, we utilized a library of over 1,000 different peptides and a high throughput MHC-peptide binding assay to detail the binding specificity of the rhesus macaque class I molecule Mamu-A*11. These studies defined the fine specificity of primary anchor positions, and dissected the role of secondary anchors, for peptides of 8-11 residues in length. This detailed information was utilized to develop size-specific polynomial algorithms to predict Mamu-A*11 binding capacity. Testing SIVmac239-derived Mamu-A* 11 binding peptides for recognition by peripheral blood mononuclear cells (PBMC) from Mamu-A*11-positive, SIV-infected macaques, identified five novel SIV-derived Mamu-A*11 epitopes. Finally, we detected extensive cross-reactivity at the binding level between Mamu-A*11 and the mouse H-2 class I molecule K k. Further experiments revealed that three out of four Mamu-A *11 binding peptides which bound Kk and were immunogenic in Kk mice were also recognized in Mamu-A*11-infected macaques. This is the first detailed description of mouse-macaque interspecies cross-reactivity, potentially useful in testing novel vaccines in mice and macaques.",
keywords = "AIDS, Epitope, Macaque, MHC, SIV",
author = "Alessandro Sette and John Sidney and Bui, {Huynh Hoa} and {Del Guercio}, {Marie France} and Jeff Alexander and John Loffredo and David Watkins and Moth{\'e}, {Bianca R.}",
year = "2005",
month = "4",
day = "1",
doi = "10.1007/s00251-004-0749-z",
language = "English",
volume = "57",
pages = "53--68",
journal = "Immunogenetics",
issn = "0093-7711",
publisher = "Springer Verlag",
number = "1-2",

}

TY - JOUR

T1 - Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity

AU - Sette, Alessandro

AU - Sidney, John

AU - Bui, Huynh Hoa

AU - Del Guercio, Marie France

AU - Alexander, Jeff

AU - Loffredo, John

AU - Watkins, David

AU - Mothé, Bianca R.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - The SIV-infected Indian rhesus macaque is the most established model of HIV infection, providing insight into pathogenesis and a system for testing novel vaccines. However, only a limited amount of information is available regarding the peptide-binding motifs and epitopes bound by their class I and class II MHC molecules. In this study, we utilized a library of over 1,000 different peptides and a high throughput MHC-peptide binding assay to detail the binding specificity of the rhesus macaque class I molecule Mamu-A*11. These studies defined the fine specificity of primary anchor positions, and dissected the role of secondary anchors, for peptides of 8-11 residues in length. This detailed information was utilized to develop size-specific polynomial algorithms to predict Mamu-A*11 binding capacity. Testing SIVmac239-derived Mamu-A* 11 binding peptides for recognition by peripheral blood mononuclear cells (PBMC) from Mamu-A*11-positive, SIV-infected macaques, identified five novel SIV-derived Mamu-A*11 epitopes. Finally, we detected extensive cross-reactivity at the binding level between Mamu-A*11 and the mouse H-2 class I molecule K k. Further experiments revealed that three out of four Mamu-A *11 binding peptides which bound Kk and were immunogenic in Kk mice were also recognized in Mamu-A*11-infected macaques. This is the first detailed description of mouse-macaque interspecies cross-reactivity, potentially useful in testing novel vaccines in mice and macaques.

AB - The SIV-infected Indian rhesus macaque is the most established model of HIV infection, providing insight into pathogenesis and a system for testing novel vaccines. However, only a limited amount of information is available regarding the peptide-binding motifs and epitopes bound by their class I and class II MHC molecules. In this study, we utilized a library of over 1,000 different peptides and a high throughput MHC-peptide binding assay to detail the binding specificity of the rhesus macaque class I molecule Mamu-A*11. These studies defined the fine specificity of primary anchor positions, and dissected the role of secondary anchors, for peptides of 8-11 residues in length. This detailed information was utilized to develop size-specific polynomial algorithms to predict Mamu-A*11 binding capacity. Testing SIVmac239-derived Mamu-A* 11 binding peptides for recognition by peripheral blood mononuclear cells (PBMC) from Mamu-A*11-positive, SIV-infected macaques, identified five novel SIV-derived Mamu-A*11 epitopes. Finally, we detected extensive cross-reactivity at the binding level between Mamu-A*11 and the mouse H-2 class I molecule K k. Further experiments revealed that three out of four Mamu-A *11 binding peptides which bound Kk and were immunogenic in Kk mice were also recognized in Mamu-A*11-infected macaques. This is the first detailed description of mouse-macaque interspecies cross-reactivity, potentially useful in testing novel vaccines in mice and macaques.

KW - AIDS

KW - Epitope

KW - Macaque

KW - MHC

KW - SIV

UR - http://www.scopus.com/inward/record.url?scp=17944382046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17944382046&partnerID=8YFLogxK

U2 - 10.1007/s00251-004-0749-z

DO - 10.1007/s00251-004-0749-z

M3 - Article

VL - 57

SP - 53

EP - 68

JO - Immunogenetics

JF - Immunogenetics

SN - 0093-7711

IS - 1-2

ER -